MWP
NKTR icon

MYCIO Wealth Partners’s Nektar Therapeutics NKTR Stock Holding History

MYCIO Wealth Partners’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5
Closed -$1K – 496
2016
Q3 		$1K Buy
+5
New +$1.29K ﹤0.01% 811
2014
Q2 		– Sell
-12
Closed -$2.12K – 647
2014
Q1 		$2K Buy
+12
New +$2.38K ﹤0.01% 587

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MYCIO Wealth Partners's NKTR Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of Nektar Therapeutics (NKTR) in Q4 2016, closing a stake of 5 shares — an estimated $1K sold.

MYCIO Wealth Partners first reported a position in NKTR in Q1 2014 and held it in 2 quarters. The position peaked at $2K in Q1 2014. 199 funds tracked by Wall St. Rank hold NKTR as of Q4 2016.

  • MYCIO Wealth Partners reported no remaining Nektar Therapeutics position as of Q4 2016 after selling out during the quarter.
  • MYCIO Wealth Partners sold 5 Nektar Therapeutics shares in Q4 2016, an estimated $1K.
  • MYCIO Wealth Partners first reported a position in Nektar Therapeutics in Q1 2014 and held it in 2 quarters.
  • MYCIO Wealth Partners's Nektar Therapeutics position peaked at $2K in Q1 2014.
  • 199 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.